𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Downregulation of VEGF-D expression by interleukin-1β in cardiac microvascular endothelial cells is mediated by MAPKs and PKCα/β1

✍ Scribed by Deidra J.H. Mountain; Mahipal Singh; Krishna Singh


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
247 KB
Volume
215
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Interleukin‐1β (IL‐1β) is a proinflammatory cytokine increased in the heart following myocardial infarction. Vascular endothelial growth factors (VEGFs) are implicated in angiogenesis due to their involvement in the recruitment and proliferation of endothelial cells. Here we studied expression of VEGFs in response to IL‐1β in rat cardiac microvascular endothelial cells (CMECs) and investigated the signaling pathways involved in the regulation of VEGF‐D. cDNA array analysis indicated that IL‐1β modulates the expression of numerous angiogenesis‐related genes, notably decreasing the expression of VEGF‐D. RT‐PCR and Western blot analyses confirmed decreased expression of VEGF‐D in response to IL‐1β. IL‐1β decreased the expression of VEGF‐C to a lesser extent with no effects on VEGF‐A or ‐B. Inhibition of ERK1/2, JNKs, or PKCα/β~1~ alone partially inhibited IL‐1β‐induced VEGF‐D downregulation. Concurrent inhibition of ERK1/2 or JNKs and PKCα/β~1~ resulted in a synergistic inhibition of IL‐1β‐induced decreases in VEGF‐D. Inhibition of ERK1/2 partially inhibited IL‐1β‐stimulated inactivation of GSK‐3β with no effect on β‐catenin levels. Inhibition of GSK‐3β using SB216763 inhibited basal VEGF‐D expression. We conclude that IL‐1β downregulates VEGF‐D expression in CMECs via the involvement of ERK1/2, JNKs, and PKCα/β~1~. This is the first report to indicate inhibition of VEGF‐D gene expression in response to IL‐1β in cardiac microvascular endothelial cells, a cell type of central interest in angiogenesis. J. Cell. Physiol. 215: 337–343, 2008. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


β-catenin mediates alteration in cell pr
✍ Viqar Syed; Paul Mak; Cheng Du; K.C. Balaji 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

## Abstract We have previously demonstrated that Protein Kinase D1 (PKD1) interacts with E‐cadherin and is associated with altered cell aggregation and motility in prostate cancer (PC). Because both PKD1 and E‐cadherin are known to be dysregulated in PC, in this study we investigated the functional

Sodium arsenite downregulates transcript
✍ Dan D. Hershko; Bruce W. Robb; Guang-jo Luo; Eric S. Hungness; Per-Olof Hasselgr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

## Abstract In recent studies, sodium arsenite (SA) inhibited IL‐6 production in cultured intestinal epithelial cells, at least in part by downregulating the activity of nuclear factor‐kappaB (NF‐κB). The influence of SA on the activity of other transcription factors regulating the interleukin‐6 (_

ERK1/2 and JNKs, but not p38 kinase, are
✍ Zhonglin Xie; Mahipal Singh; Krishna Singh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

## Abstract Osteopontin (OPN), also called cytokine Eta‐1, expressed in the myocardium co‐incident with heart failure plays an important role in post myocardial infarction (MI) remodeling by promoting collagen synthesis and accumulation. Angiotensin II (Ang II) and inflammatory cytokines are increa

Expression of proangiogenic chemokine Gr
✍ Elena Loukinova; Zhong Chen; Carter Van Waes; Gang Dong 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 186 KB

## We previously reported that chemokine Growth Regu lated Oncogene 1 (Gro 1) is over-expressed in murine squamous cell carcinoma (SCC) with metastatic tumor progression. The enhanced expression of Gro-1 gene by SCC is regulated by activation of nuclear factor-B (NF-B), leading to accelerated tumor